Modular Medical makes Pivot pump commercially available
By HME News Staff
Updated 11:05 AM CDT, Thu June 25, 2026
SAN DIEGO – Modular Medical says its Pivot tubeless insulin patch pump is now commercially available in the U.S., following 510(k) clearance from the U.S. Food and Drug Administration (FDA) in April, marking its transition to a commercial-stage medical device company. The company expects its full commercial launch to roll out in phases, initially targeting select high-volume endocrinology practices and expanding across multiple metropolitan markets by late 2026. "As only the second fully electronic tubeless pump on the U.S. market, Pivot is positioned to serve a large, underserved ‘almost-pumper' population,” said Jeb Besser, CEO of Modular Medical. “With first shipments beginning this week, we are focused on disciplined execution, as we scale adoption and seek to build long-term value for patients and shareholders." Pivot is designed for insulin-dependent adults with diabetes who remain on multiple daily injections and who may face cost, complexity or usability barriers with traditional pump systems. Modular Medical says about 70% of insulin-dependent adults remain on multiple daily injections, representing a large potential market for the product. The pump has a removable two-part design, 3 mL reservoir, intuitive interface, and flexible, wearable form factor intended to support activities such as showering and sports. No battery recharging is required.
Comments